跳至主要内容
临床试验/NCT04998656
NCT04998656已完成不适用

Werewolf Flow 50 During ACL Reconstruction: A Randomized Control Trial

University of Colorado, Denver6 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2021年7月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
6
主要终点
Rates of Post-Operative Arthrofibrosis

研究概览

简要总结

The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using a randomized control trial design.

The investigators hypothesize that a lower proportion of participants who undergo ACLR and are randomized to the Werewolf FLOW50 procedure will experience post-operative arthrofibrosis compared to those randomized to standard of care (control group).

详细描述

The investigators foresee minimal risks to participants. The Werewolf FLOW50 is an FDA approved medical device to be used in the knee joint. he surgeon performing each surgery has used both the Werewolf FLOW50 device (according to FDA-approved indications for use) and no electrocautery device as standard of care during ACL reconstruction surgery.

There is minimal risk associated with the subsequent MRI. Participants may experience slight discomfort from the confined space, flashing lights in their eyes, or temporary warmth/reddening of the skin following MRI. Participants will be informed of these risks and discomforts and pregnant participants or those with any metal and/or electronic devices inside their bodies will not receive the MRI.

There is the risk of unintended disclosure of protected health information (PHI) to individuals outside the research team. To mitigate this risk, data points are entered into a password-protected, HIPAA compliant REDCap database accessible to only the PIs and study personnel. Children's Colorado affiliated and approved study personal will have access to all study information collected at all involved study sites. However, other study sites will only have access to the information collected on patients enrolled at their site. We believe this system will contribute to the protection of PHI. The only PHI collected will be visit dates; all participants will be linked to their information via a unique study identifier.

The PI will periodically review the status of this protocol. Any unanticipated problems will be disclosed to COMIRB [Colorado Multiple Institutional Review Board] within five days with a cover letter detailing the assessment and actions to be taken.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Participants will not be told whether the Werewolf Flow 50 device was used during their surgery or not.

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 12-18 (inclusive) at time of surgery
  • Scheduled to undergo ACL reconstruction performed at Children's Hospital Colorado or associated network of care site.

排除标准

  • Underlying congenital or musculoskeletal disorders
  • Pregnant females, prisoners, and wards of the state
  • Persons deemed incompetent and those who have limited decision-making capacity

研究组 & 干预措施

Werewolf FLOW 50 Group

Active Comparator

The Werewolf FLOW 50 electrocautery device will be used during surgical treatment for patients assigned to this group.

干预措施: Werewolf FLOW 50 (Device)

Control Group

Placebo Comparator

No electrocautery device will be used during surgical treatment for patients assigned to this group.

干预措施: Control (Other)

结局指标

主要结局

Rates of Post-Operative Arthrofibrosis

时间窗: 1 year post-operative

Number of participants with post-operative arthrofibrosis

次要结局

  • Range of Motion(1 year post-operative)
  • Patient Reported Outcomes(1 year post-operative)
  • Complications(1 year post-operative)
  • Range of Motion - Knee(1 year post-operative)
  • Patient-Reported Outcomes Measurement Information System (PROMIS)(Data reported below were collected approximately 6-months post-operatively.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验